Back to Journals » Pediatric Health, Medicine and Therapeutics » Volume 3

Optimal management of pediatric obsessive-compulsive disorder

Authors Ung, Ale, Storch E

Received 29 February 2012

Accepted for publication 28 March 2012

Published 3 May 2012 Volume 2012:3 Pages 9—18


Review by Single anonymous peer review

Peer reviewer comments 2

Download Article [PDF] 

Danielle Ung1, Chelsea M Ale2, Eric A Storch1–3
1Department of Psychology, 2Department of Pediatrics, 3Department of Psychiatry and Behavioral Neuroscience, University of South Florida, Tampa, FL, USA

Abstract: The last two decades have seen an increase in evidence supporting behavioral and pharmacologic treatments of pediatric obsessive-compulsive disorder, a debilitating anxiety disorder that affects about 1% of youth. However, dissemination of knowledge about these treatments to pediatric health care providers and families of affected children has been less successful. Following best practice guidelines, specific evidence for cognitive-behavioral therapy with exposure and response prevention and pharmacotherapy with serotonin reuptake inhibitors are presented. A discussion of clinical features and their impact on treatment delivery and empirically based suggestions for overcoming these barriers are also presented. Future directions for enhancing treatment implementation and dissemination are discussed.

Keywords: obsessive-compulsive disorder, children, treatment, cognitive-behavioral therapy, serotonin reuptake inhibitors, antidepressant medication

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]